Company intelligence / Profile preview

Purgo Biologics

Seongnam-si, Gyeonggi-do, SOUTH KOREAfacebook.com ↗

Ownership: Private
Development stage: Commercial

Overview

Purgo Biologics has commercialized a portfolio of biomaterials for dental applications including porcine-derived bone grafts and collagen membranes. Their products are used worldwide for soft tissue and alveolar bone regeneration with regulatory clearances such as FDA Class II device status. Clinical results support their use in guided bone/tissue regeneration.

Therapeutic areas: Other
Modalities: Biomaterial (bone grafts)Biomaterial (collagen membranes)Device (dental barrier membranes and sutures)
Industry: Implantable Medical Devices

Partnerships

Collaborative research with government agencies, clinicians & educational institutions globally; distribution partnerships not specifically named.

Beyond the preview

Go deeper on Purgo Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Purgo Biologics.

Explore the full profile